Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Circa Pharmaceuticals

Executive Summary

Pleads nolo contendere Oct. 20 in Baltimore federal court to price-fixing charge. Circa (formerly Bolar) and its VP-Financial Affairs Lawrence Raisfeld, were charged last December with conspiring with Vitarine Pharmaceuticals to fix the price of generic Dyazide ("The Pink Sheet" Dec. 21, 1992, p. 17). Raisfeld also pled no contest and was fined $20,000. Circa paid the government $1 mil. and will now defend civil actions brought by General Generics and Spawd, Inc. Those suits were stayed pending the resolution of the criminal case.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS023476

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel